title: Multifaceted chemotherapy for trilateral retinoblastoma.
authors.affiliation: Division of Hematology and Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
authors.forename: Helen
authors.initials: H
authors.lastname: Dimaras
authors.forename: Elise
authors.initials: E
authors.lastname: Héon
authors.forename: John
authors.initials: J
authors.lastname: Doyle
authors.forename: Caron
authors.initials: C
authors.lastname: Strahlendorf
authors.forename: Katherine E
authors.initials: KE
authors.lastname: Paton
authors.forename: William
authors.initials: W
authors.lastname: Halliday
authors.forename: Paul
authors.initials: P
authors.lastname: Babyn
authors.forename: Brenda L
authors.initials: BL
authors.lastname: Gallie
authors.forename: Helen S L
authors.initials: HS
authors.lastname: Chan
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016190:Carboplatin / Q000008:administration & dosage; D016572:Cyclosporine / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007223:Infant; D008279:Magnetic Resonance Imaging; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy* / Q000473:pathology; D010870:Pineal Gland / Q000187:drug effects* / Q000473:pathology; D019572:Retinal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D012175:Retinoblastoma / Q000188:drug therapy* / Q000473:pathology; D014057:Tomography, X-Ray Computed; D019772:Topotecan / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D014750:Vincristine; D005047:Etoposide; D019772:Topotecan; D016572:Cyclosporine; D016190:Carboplatin